Article Details

New in Israel: Antibody doses for high-risk COVID cases straight after diagnosis

Retrieved on: 2021-02-15 16:50:21

Tags for this article:

Click the tags to see associated articles and topics

New in Israel: Antibody doses for high-risk COVID cases straight after diagnosis. View article details on hiswai:

Excerpt

Bamlanivimab is composed of monoclonal antibodies, which are laboratory-made proteins that mimic the immune system's ability to fight off harmful ...

Article found on: www.timesofisrael.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up